Skip to main content
PolicySpeak
← All files
ME

MD-EX

Other · France

not in the EU Transparency RegisterThis organization files on consultations without a register number, so its record here is built from its filings alone. Register facts — staff, costs, accreditations — are not available for it.

2
positions filed
in the 583 files tracked
2
legislative files
of 583 tracked
1
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.

Track MD-EX in PolicySpeak: request access →

Work at MD-EX? so we know who speaks for it.

Follow the files MD-EX engages with

One email on Tuesdays when a new position is filed on these 2 files, from MD-EX or from anyone else on them. Only when there is something new.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Their record over time

MD-EX filed 2 positions between 13 Jan 2023 and 21 Jan 2026, across 2 of the 583 legislative files tracked here, attaching a full position paper 1 time.

2023 · 1 filed2026 · 1 filed

What they argued

Transitional provisions for certain medical devices and in vitro diagnostic medical devicesfiled 13 Jan 2023source

Dear, First I want to thank you to permit to give our feedback. Below some questions/ comments : - Harmonization for qualification of product reviewer and recognition at European Level RDM 2017/745 Annex VII §3.2.5 Criteria for qualification of product reviewer is not sufficiently detailed in RDM 2017/745 and subject to the interpretation and not harmonization between NB regarding qualification.

Implementing rules regarding requirements to be met by notified bodiesfiled 21 Jan 2026PDFsource

I fully share the objective of this revision. It is indeed essential to adapt the regulatory framework in order to enable companies, particularly SMEs, to cope with requirements that can sometimes be disproportionate, with unpredictable timelines and an administrative burden that has become difficult to sustain.

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Put MD-EX next to another organization. Same files, same register facts, side by side. Compare →

Turns up on the same files

Organizations that also filed on at least two of the same consultations. A shared interest in the same dossiers — not evidence of coordination, and we do not suggest any.

Is this your organization?

Everything on this page comes from MD-EX’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.